| Ex-Dividend Date | Record / Pay Date | Cash Distribution | Status / Corporate Action |
|---|---|---|---|
| 2026-09-30 | 2026-10-15 | $1.3000 | Regular Distribution |
| Commercial Asset / Property Name | Location | Rentable Sq Ft | Occupancy | Implied Asset Valuation |
|---|---|---|---|---|
| Kendall Square Mega-Campus | Cambridge, MA | 940,000 sq ft | 89.2% | SEC Sched III |
| Alexandria Center for Life Science - NYC | New York, NY | 720,000 sq ft | 88.5% | SEC Sched III |
| Torrey Pines Science Center | San Diego, CA | 480,000 sq ft | 94.5% | SEC Sched III |
| Torrey Pines Life Science Research Center | San Diego, CA | 420,000 sq ft | 83.1% | SEC Sched III |
| Quantitative Risk & Return Metric | ARE | VNQ (Benchmark) | Institutional Delta / Spread |
|---|---|---|---|
|
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
|
1.74 | 1.00 | +0.74 (High Beta (Aggressive Leverage)) |
|
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
|
-50.02% | 0.00% (Baseline) | Trailing VNQ |
|
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
|
-0.95 | 0.04 | -0.99 |
|
Sortino Ratio
Downside semi-variance risk-adjusted return
|
-0.86 | 0.03 | -0.89 |
|
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
|
48.2% | 13.9% | +34.3% (Higher Volatility) |
|
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
|
-46.5% | -11.4% | -35.1% vs VNQ |
|
1-Year Trailing Return (CAGR)
Compounded annual growth rate
|
-41.3% | 4.1% | -45.4% Spread |
|
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
|
R² 0.25 | Corr: 0.5 | 25% variance explained by VNQ |
|
Trading Session Win Rate
Percentage of positive daily closing sessions
|
49.6% | 51.6% | -2.0% vs Benchmark |